An in vitro evaluation of the effect of probiotics and prebiotics on the metabolic profile of human microbiota

Anaerobe

Volumn 18, Issue 4, 2012, Pages 386-391

  Vitali, Beatrice ^a   Ndagijimana, Maurice ^a,b   Maccaferri, Simone ^a   Biagi, Elena ^a   Guerzoni, Maria Elisabetta ^a   Brigidi, Patrizia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fecal metabolic profiles; Gut microbiota; Prebiotics; Probiotics

Indexed keywords

2 BUTANONE; 2 METHYL 5 ETHYL PYRAZINE; 2 METHYL BUTYRATE; ALCOHOL; ALDEHYDE; ALKADIENE; BUTANDIENE; BUTYRIC ACID; BUTYRIC ACID DERIVATIVE; CARBOXYLIC ACID; ESTER; FRUCTOSE OLIGOSACCHARIDE; HYDROCARBON; KETONE; NITROGEN DERIVATIVE; PHENOL; PREBIOTIC AGENT; PROBIOTIC AGENT; PYRAZINE DERIVATIVE; PYRIDINE; SULFUR DERIVATIVE; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BATCH FERMENTATION; BIFIDOBACTERIUM LONGUM; FECES ANALYSIS; FEMALE; HUMAN; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS HELVETICUS; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; MICROBIAL METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; SOLID PHASE MICROEXTRACTION;

BATCH CELL CULTURE TECHNIQUES; BIFIDOBACTERIUM; BUTANONES; BUTYRATES; CULTURE MEDIA; FECES; FERMENTATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS HELVETICUS; METABOLOME; METAGENOME; MICROBIAL SENSITIVITY TESTS; PREBIOTICS; PROBIOTICS; PYRIDINES; SYNBIOTICS;

BIFIDOBACTERIUM LONGUM; LACTOBACILLUS HELVETICUS;

EID: 84864363704     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2012.04.014     Document Type: Article

References (20)

1. Collins M.D., Gibson G.R. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999, 69:1052S-1057S.
2. Gibson G.R., Beatty E.R., Wang X., Cummings J.H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995, 108:975-982.
3. Kleerebezem M., Vaughan E.E. Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu Rev Microbiol 2009, 63:269-290.
4. FAO/WHO Guidelines for the evaluation of probiotics in food. London, Ontario: Food and Agriculture Organization of United Nations and World Health Organization Working Group report 2002.
5. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003, 361:512-519.
6. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995, 125:1401-1412.
7. Rook G.A., Brunet L.R. Microbes, immunoregulation, and the gut. Gut 2005, 54:317-320.
8. De Preter V., Raemen H., Cloetens L., Houben E., Rutgeerts P., Verbeke K. Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. Eur J Clin Nutr 2008, 62:225-231.
9. Ndagijimana M., Laghi L., Vitali B., Placucci G., Brigidi P., Guerzoni M.E. Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by (1)H Nuclear Magnetic Resonance spectroscopy. Int J Food Microbiol 2009, 134:147-153.
10. Vitali B., Ndagijimana M., Cruciani F., Carnevali P., Candela M., Guerzoni M.E., et al. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010, 10:4.
11. Rezzi S., Ramadan Z., Fay L.B., Kochhar S. Nutritional metabonomics: applications and perspectives. J Proteome Res 2007, 6:513-525.
12. Garner C.E., Smith S., de Lacy Costello B., White P., Spencer R., Probert C.S., et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J 2007, 21:1675-1688.
13. Macfarlane G.T., Macfarlane S., Gibson G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 1998, 35:180-187.
14. Ndagijimana M., Vallicelli M., Cocconcelli P.S., Cappa F., Patrignani F., Lanciotti R., et al. Two 2[5H]-furanones as possible signaling molecules in Lactobacillus helveticus. Appl Environ Microbiol 2006, 72:6053-6061.
15. Maccaferri S., Vitali B., Klinder A., Kolida S., Ndagijimana M., Laghi L., et al. Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother 2010, 65:2556-2565.
16. Ganesan B., Dobrowolski P., Weimer B.C. Identification of the leucine-to-2-methylbutyric acid catabolic pathway of Lactococcus lactis. Appl Environ Microbiol 2006, 72:4264-4273.
17. Serrazanetti D.I., Ndagijimana M., Sado S.L., Corsetti A., Vogel R.F., Ehrmann M.A., et al. Acid stress-mediated metabolic shift in Lactobacillus sanfranciscensis LSCE1. Appl Environ Microbiol 2001, [Epub ahead of print].
18. Duncan S.H., Louis P., Flint H.J. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004, 70:5810-5817.
19. Knasmuller S., Steinkellner H., Hirschl A.M., Rabot S., Nobis E.C., Kassie F. Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines. Mutat Res 2001, 480:129-138.
20. Vanhaecke L., Vercruysse F., Boon N., Verstraete W., Cleenwerck I., De Wachter M., et al. Isolation and characterization of human intestinal bacteria capable of transforming the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Appl Environ Microbiol 2008, 74:1469-1477.